National leadership group for preventing and treating infectious diseases
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
This program supports testing vaccines, treatments, and diagnostic tools for people affected by respiratory, gut, tropical, and sexually transmitted infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11245703 on NIH RePORTER |
What this research studies
This program brings together experts at eight universities to plan and run clinical studies that test vaccines, biologic therapies, drugs, and diagnostic tools for infections of the lungs, gut, tropical diseases, and STIs. It supports Phase I–IV and first‑in‑human work, helps with regulatory steps like INDs and single IRBs, and coordinates public–private partnerships. The group works with hospitals and clinics nationally and internationally and focuses on enrolling diverse populations. From a patient view, the program aims to speed safe testing and delivery of new prevention and treatment options when outbreaks or unmet needs arise.
Who could benefit from this research
Good fit: People with respiratory or enteric infections, malaria/tropical diseases, sexually transmitted infections, or those eligible as healthy volunteers for early‑phase studies at participating sites are the likely candidates.
Not a fit: Patients without the targeted infections or who live far from participating hospitals and clinics or who do not meet trial eligibility criteria are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, it could speed development and delivery of better vaccines, treatments, and diagnostics for several common and emerging infectious diseases.
How similar studies have performed: Similar NIAID-supported clinical trial networks have successfully supported vaccine and therapeutic development, so this builds on proven infrastructure and experience.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Stephens, David S — Emory University
- Study coordinator: Stephens, David S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.